Infrastructure Capital Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,500
Closed -$527K 89
2022
Q1
$527K Buy
+2,500
New +$544K 0.08% 57
2021
Q4
Sell
-4,000
Closed -$1.14M 39
2021
Q3
$1.14M Buy
4,000
+3,379
+544% +$1.11M 0.18% 28
2021
Q2
$215K Buy
+621
New +$188K 0.04% 58
2019
Q4
Sell
-1,000
Closed -$233K 96
2019
Q3
$233K Sell
1,000
-540
-35% -$126K 0.03% 86
2019
Q2
$360K Buy
1,540
+300
+24% +$69.3K 0.04% 74
2019
Q1
$293K Buy
+1,240
New +$390K 0.04% 73
2018
Q4
Sell
-1,375
Closed -$486K 86
2018
Q3
$486K Sell
1,375
-375
-21% -$129K 0.05% 80
2018
Q2
$508K Buy
1,750
+700
+67% +$197K 0.05% 76
2018
Q1
$288K Sell
1,050
-2,667
-72% -$828K 0.03% 89
2017
Q4
$1.18M Buy
3,717
+1,032
+38% +$331K 0.12% 48
2017
Q3
$841K Buy
2,685
+34
+1% +$10.1K 0.09% 55
2017
Q2
$719K Buy
2,651
+100
+4% +$26.4K 0.11% 57
2017
Q1
$697K Sell
2,551
-1,800
-41% -$509K 0.16% 55
2016
Q4
$1.14M Buy
+4,351
New +$1.29M 0.38% 40

Other funds holding BIIB

Infrastructure Capital Advisors's BIIB Position: Q2 2022 in Review

Infrastructure Capital Advisors sold out of Biogen (BIIB) in Q2 2022, closing a stake of 2,500 shares — an estimated $527K sold.

Infrastructure Capital Advisors first reported a position in BIIB in Q4 2016 and held it in 14 quarters. The position peaked at $1.18M in Q4 2017. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Infrastructure Capital Advisors reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Infrastructure Capital Advisors sold 2,500 Biogen shares in Q2 2022, an estimated $527K.
  • Infrastructure Capital Advisors first reported a position in Biogen in Q4 2016 and held it in 14 quarters.
  • Infrastructure Capital Advisors's Biogen position peaked at $1.18M in Q4 2017.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Infrastructure Capital Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.